Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model. - Wikidata - awgldk - TriplyDB

Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model.

Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model.

http://www.wikidata.org/entity/Q39736645

about

Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma Final trial report of sentinel-node biopsy versus nodal observation in melanoma.Challenges and solutions to pre- and post-randomization subgroup analyses.Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: response to 'No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisa Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal.When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'.No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.Sentinel lymph node biopsy for melanoma: a plea to let the data be heard.MSLT-I-response of clinical trial investigators.Sentinel lymph node biopsy for melanoma: a plea to let the data speak.Predicting disease Risk by Transformation Models in the Presence of Unspecified Subgroup Membership.

P2860

Q24187945-88E80F1D-C404-43D5-9C34-D8437D1C0E27 Q33760173-9161CFC7-927A-44D9-9400-8D6D04D596E8 Q34356025-0031A1F9-6374-4962-88D9-75D8A735A5B7 Q35624171-091AE4E6-3D56-4E39-8A1E-C7530E94AEA8 Q39434556-61EA237D-9C76-40D6-97AB-951DBD9F0BEF Q39441123-4A889CE8-D067-4E1D-8443-3739D36CE59B Q41209498-E3CC9B1D-718D-4819-A835-EF37537A6E54 Q42411719-03B06323-CCB1-44D3-BF0C-E1465079E4C6 Q46125629-ECDF6B4F-84FB-4BE5-B13F-CC257C698621 Q46134083-0FEB3DD8-1480-4F3D-870A-86CA173D483C Q47621530-8DF21E20-B1DC-4DCD-9BFD-144E9EC42EE4

P2860

Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model.

http://www.wikidata.org/entity/Q39736645

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Latent subgroup analysis of a ...... ed failure time mixture model.

@en

Latent subgroup analysis of a ...... ed failure time mixture model.

@nl

type

label

Latent subgroup analysis of a ...... ed failure time mixture model.

@en

Latent subgroup analysis of a ...... ed failure time mixture model.

@nl

prefLabel

Latent subgroup analysis of a ...... ed failure time mixture model.

@en

Latent subgroup analysis of a ...... ed failure time mixture model.

@nl

P1433

Q39736645-836869EC-F5A3-4CAA-86AF-F1BF424058B1

P1476

Q39736645-0C85715C-3AC2-4BCC-BC09-0F39179D28F8

P2093

Q39736645-5C51C69C-EE9B-434B-BCFD-9E7FB1DB49DF

Q39736645-C1542CFD-F115-425C-BF0C-F1CAEF3F69A1

P2860

Q39736645-018C859E-2968-4BCB-BF71-57B796AC5B3A

Q39736645-0E5F3FDF-9F9D-452A-8741-A77FEF01D8FC

Q39736645-27FB03F3-3A7C-4D7F-8723-ECEEC5E1196E

Q39736645-2971C6B2-61ED-4F8B-A7D1-2FCB0320657A

Q39736645-30D2B96D-0DC4-4033-8514-B79E8198FC19

Q39736645-3DBE2C73-FC66-4D1B-94B1-C633FA155E40

Q39736645-54ABE862-EEA9-4A36-8287-DF837124D5A0

Q39736645-74D5FA22-24AC-4E42-B343-645699105160

Q39736645-909A5554-1026-4AD6-8E44-3CA7BC7F71B5

Q39736645-A2E5008B-19F9-4247-AF7E-4B131D3A17A3

P304

Q39736645-1E72917C-2526-44F2-9DD9-165362B7CAC6

P31

Q39736645-753879BB-7E8D-4056-A534-5F37919F037A

P356

Q39736645-30E66933-EDAB-4B90-9014-981C596DE4DD

P407

Q39736645-C860EBF8-8685-4522-B40D-E2B8CCDB9AD6

P433

Q39736645-C038B60A-BA22-4583-9EC1-C3F0B523FCBE

P478

Q39736645-74C2DF44-9AB3-443F-B4CE-ED49511E29F1

P577

Q39736645-FE9454D4-FBB4-4AF9-9BB1-0D8415559774

P698

Q39736645-8AC49D7F-3CFA-49DF-909D-DCBE39282C9A

P932

Q39736645-42B05F55-5279-45A2-B377-3406441B4A9A

P356

J.1541-0420.2012.01818.X

P1433

P1476

Latent subgroup analysis of a ...... ed failure time mixture model.

@en

P2093

G Li

http://www.w3.org/2001/XMLSchema#string

L Altstein

http://www.w3.org/2001/XMLSchema#string

P2860

The challenge of subgroup analyses--reporting without distorting

BJ: an S-Plus program to fit linear regression models to censored data using the Buckley-James method.

An extended general location model for causal inferences from data subject to noncompliance and missing values.

On estimating efficacy from clinical trials.

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.

The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis.

Sentinel-node biopsy or nodal observation in melanoma.

New fields of application of the sentinel lymph node biopsy in the pathologic staging of solid neoplasms: review of literature and surgical perspectives.

Nonparametric inference for assessing treatment efficacy in randomized clinical trials with a time-to-event outcome and all-or-none compliance

A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial.

P304

52-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1541-0420.2012.01818.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23383608

http://www.w3.org/2001/XMLSchema#string

P932

3622121

http://www.w3.org/2001/XMLSchema#string